Our lab and others have identified the vasculature as a main compartment of ephrinB2 activity in multiple cancer types including HNSCC (Bhatia et al., 2022; Broggini et al., 2022; Héroult et al., 2010; Noren et al., 2004). This evidence concerns the gene EFNB2 and cancer.